DBET1
DBET1 is a cereblon-directed PROTAC that degrades BET proteins with an in vitro EC50 of 430 nM, leading to apoptosis. This molecular tool is widely used in oncology research to study BET protein function and has demonstrated activity in cellular and animal models of cancer.
Product Specifications
CAS Number
1799711-21-9
Product Name Alternative
PROTACs, dBET1, dBET-1, dBET 1, BET, inhibit, Epigenetic Reader Domain, EpigeneticReaderDomain, Inhibitor
Field of Research
Epigenetics & Chromatin, Pharmacology & Drug Discovery
Purity
98.02% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (4.2 mM) ; DMSO:50 mg/mL (63.67 mM) ; H2O:Insoluble; Ethanol:5 mg/mL (6.37 mM)
Smiles
CC=1C2=C (N3C ([C@H] (CC (NCCCCNC (COC4=C5C (C (=O) N (C5=O) C6C (=O) NC (=O) CC6) =CC=C4) =O) =O) N=C2C7=CC=C (Cl) C=C7) =NN=C3C) SC1C
Molecular Formula
C38H37ClN8O7S
Molecular Weight
785.27
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ENTPD2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Cell Viability Imaging Kit (Blue/Red), Hoechst 33342/PI
CPT2, CT (Carnitine O-palmitoyltransferase 2, Mitochondrial, Carnitine Palmitoyltransferase II, CPT II, CPT1) (FITC)
CPT2, CT (Carnitine O-palmitoyltransferase 2, Mitochondrial, Carnitine Palmitoyltransferase II, CPT II, CPT1) (FITC)